BNP Paribas Financial Markets
GBIO

BNP Paribas Financial Markets’s Generation Bio GBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-147
Closed -$835 – 5939
2025
Q4 		$835 Sell
147
-7
-5% -$40 ﹤0.01% 5419
2025
Q3 		$942 Sell
154
-17
-10% -$88 ﹤0.01% 5244
2025
Q2 		$546 Sell
171
-1,321
-89% -$5.09K ﹤0.01% 5215
2025
Q1 		$6.04K Sell
1,492
-357
-19% -$2.51K ﹤0.01% 4820
2024
Q4 		$19.6K Buy
+1,849
New +$33K ﹤0.01% 4727

Other funds holding GBIO

ACM
Accent Capital Management Centerville, Ohio $231M AUM 33.86% 1-Year Est. Return

BNP Paribas Financial Markets's GBIO Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 147 shares — an estimated $835 sold.

BNP Paribas Financial Markets first reported a position in GBIO in Q4 2024 and held it in 5 quarters. The position peaked at $19.6K in Q4 2024. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 147 Generation Bio shares in Q1 2026, an estimated $835.
  • BNP Paribas Financial Markets first reported a position in Generation Bio in Q4 2024 and held it in 5 quarters.
  • BNP Paribas Financial Markets's Generation Bio position peaked at $19.6K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.